Showing results (181-190 of 370) with videos related to
Sort By:
Pageof 37
Cancer Research|April 15, 1991
Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factorD S Hoon, M Banez, E Okun, et al.International Archives of Allergy and Applied Immunology|January 1, 1990
Hanganutziu-Deicher antigen as a possible target for immunotherapy of melanomaH Nakarai, P J Chandler, K Kano, et al.Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1991
The importance of anatomic site in prognosis in patients with cutaneous melanomaJ H Wong, L Wanek, L J Chang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neckD L Morton, D R Wen, L J Foshag, et al.Clinical and Experimental Immunology|January 1, 1980
A serologic study of cultured breast cancer cell lines: lack of antibody response to tumour specific membrane antigens in patientsM Higuchi, D S Robinson, R Cailleau, et al.Journal of Surgical Oncology|April 1, 1986
Adjuvant chemo-immunotherapy in stage II carcinoma of the breastA E Giuliano, F C Sparks, K Patterson, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1994
A decapeptide (Gln-Asp-Leu-Thr-Met-Lys-Tyr-Gln-Ile-Phe) from human melanoma is recognized by CTL in melanoma patientsN Morioka, Y Kikumoto, D S Hoon, et al.Cancer Research|October 15, 1991
Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomasD S Hoon, E Okun, M Banez, et al.Journal of Clinical & Laboratory Immunology|August 1, 1990
Differential effects of granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor on tumor necrosis factor and interleukin-1 production in human monocytesR Essner, K Rhoades, W H McBride, et al.Annals of Surgical Oncology|June 23, 2000
TA90-IC, a new marker for advanced colon cancerN Habal, R K Gupta, A J Bilchik, et al.Pageof 37